Mario Fabri

2PUBLICATIONS
23CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 29, 2026
A STAT1/ETC/GBP1 axis represents a potential therapeutic target for noncommunicable granulomatous skin disease.

|Sep 28, 2022
An LKB1-mitochondria axis controls TH17 effector function.

Francesc Baixauli, Klara Piletic, Daniel J Puleston

Pageof 1

Frequent Collaborators

2 joint publications

David O'Sullivan

2 joint publications

David E Sanin

2 joint publications

Erika L Pearce

1 joint publications

Daniel J Puleston